Biomarkers · Nutritional
Serum beta-Cryptoxanthin
The published study could not tell whether risk rises or falls: its 95% interval includes no change. No risk curve catalogued yet.
Published risk of death1.52×lowest vs highest tertile of serum beta-cryptoxanthin (95% CI 1.00–2.32) · Independently living Dutch elderly aged 65-85 y, health survey 1991/1992
Serum beta-Cryptoxanthin by age and sex
Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.
The percentiles as a table
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 2.53 | 4.41 | 7.04 | 11.1 | 23.6 | 1,377 | NHANES 2017-2018 |
| All | 40-59 | 2.21 | 4.21 | 6.67 | 10.5 | 25.2 | 1,499 | NHANES 2017-2018 |
| All | 60+ | 1.66 | 3.37 | 5.47 | 9.37 | 25.8 | 1,824 | NHANES 2017-2018 |
| All | all | 2.08 | 4.02 | 6.46 | 10.4 | 24.7 | 4,700 | NHANES 2017-2018 |
| Men | 20-39 | 2.86 | 4.66 | 6.81 | 10.8 | 23.2 | 661 | NHANES 2017-2018 |
| Men | 40-59 | 2.23 | 4.15 | 7.26 | 10.8 | 22.7 | 706 | NHANES 2017-2018 |
| Men | 60+ | 1.37 | 3.00 | 4.96 | 8.47 | 19.7 | 926 | NHANES 2017-2018 |
| Men | all | 2.05 | 4.00 | 6.50 | 10.5 | 22.5 | 2,293 | NHANES 2017-2018 |
| Women | 20-39 | 2.21 | 4.16 | 7.22 | 11.4 | 23.9 | 716 | NHANES 2017-2018 |
| Women | 40-59 | 2.09 | 4.29 | 6.36 | 9.84 | 28.4 | 793 | NHANES 2017-2018 |
| Women | 60+ | 1.83 | 3.53 | 5.71 | 10.1 | 28.7 | 898 | NHANES 2017-2018 |
| Women | all | 2.09 | 4.03 | 6.39 | 10.4 | 27.5 | 2,407 | NHANES 2017-2018 |
What studies found when this marker was changed
They describe what happened in those study groups, not a recommendation. See all catalogued interventions.
Measured changes in Serum beta-Cryptoxanthin, study by study
2 effects with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Study results in the groups studied, not predictions for a person.
Things that worsen it
| Type | Condition or exposure | Reported effect | Evidence | Source |
|---|---|---|---|---|
| diet | Sucrose polyester (SPE) fat replacer 17 g/day in chips and spread for 1 year vs control in adults with low or high habitual fruit and vegetable intake | Serum lipid-adjusted beta-cryptoxanthin fell 18% vs control after 1 year on 17 g/day SPE (P < 0.001); n=380 across 4 arms | RCT | Broekmans WM, Klöpping-Ketelaars IA, Weststrate JA, et al. J Nutr… |
| nutraceutical | Plant sterol or stanol consumption (average 2.5 g/day) vs control in randomized controlled trials | Plasma beta-cryptoxanthin fell 10.6% (95% CI -14.3 to -6.9) non-standardized (-4.8% TC-standardized) vs control; 41 RCTs, n=3306; duration not stated | meta-analysis | Baumgartner S, Ras RT, Trautwein EA, Mensink RP, Plat J. Eur J Nutr… |